UPDATE 1-ANALYSTS DOWNGRADE REGENERON; SHARES FALL - REUTERS

June 5( Reuters) - Credit Suisse as well as Morgan Stanley downgraded Regeneron Pharmaceuticals Inc( REGN. O: Quote, Profile, Research), receiving a some-more discreet perspective upon a company’s cancer drug, aflibercept, promulgation Regeneron shares down as most as twenty-two. ..

Tags: , , , , , ,

Related posts

Leave a Comment

Please note: Comment moderation is enabled and may delay your comment. There is no need to resubmit your comment.